These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2975501)

  • 41. Identification and some properties of a new fast-reacting plasmin inhibitor in human plasma.
    Collen D
    Eur J Biochem; 1976 Oct; 69(1):209-16. PubMed ID: 136345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in clot lysis among patients demonstrated in vitro with three thrombolytic agents (tissue-type plasminogen activator, streptokinase and urokinase).
    Musselman DR; Tate DA; Oberhardt BJ; Abruzzini AF; Blauwet MB; Koch G; Dehmer GJ
    Am J Cardiol; 1994 Mar; 73(8):544-9. PubMed ID: 8147298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.
    Zhalyalov AS; Panteleev MA; Gracheva MA; Ataullakhanov FI; Shibeko AM
    PLoS One; 2017; 12(7):e0180668. PubMed ID: 28686711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Streptokinase-producing streptococci grown in human plasma acquire unregulated cell-associated plasmin activity.
    Lottenberg R; DesJardin LE; Wang H; Boyle MD
    J Infect Dis; 1992 Aug; 166(2):436-40. PubMed ID: 1386099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The acyl-enzymes and pro-urokinase: promising new thrombolytic agents.
    Samama M; Horellou MH; Nguyen G; Conard J
    Haemostasis; 1986; 16 Suppl 3():33-7. PubMed ID: 3095196
    [No Abstract]   [Full Text] [Related]  

  • 46. [Thrombolytic drugs in acute myocardial infarct].
    Ambrosioni E; Degli Esposti D
    Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Activation of complement and kinin systems after thrombolytic therapy in patients with acute myocardial infarction. A comparison between streptokinase and recombinant tissue-type plasminogen activator.
    Agostoni A; Gardinali M; Frangi D; Cafaro C; Conciato L; Sponzilli C; Salvioni A; Cugno M; Cicardi M
    Circulation; 1994 Dec; 90(6):2666-70. PubMed ID: 7994806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Theoretical bases of thrombolytic therapy].
    Verstraete M
    Pathol Biol (Paris); 1975 Mar; 23(3):239-45. PubMed ID: 124849
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Kinetics of in vitro fibrinolysis by plasmin and a plasmin-streptokinase equimolar complex].
    Aĭsina RB; Zhitkova IuV; Eremeev NL; Popova GIu; Kazanskaia NF
    Ukr Biokhim Zh (1978); 1991; 63(1):20-6. PubMed ID: 1827551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrin.
    Fears R; Hibbs MJ; Smith RA
    Biochem J; 1985 Jul; 229(2):555-8. PubMed ID: 4041182
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interaction of immobilized human plasminogen and plasmin with streptokinase.
    Shi GY; Chang BI; Wu DH; Wu HL
    Biochem Biophys Res Commun; 1993 Aug; 195(1):192-200. PubMed ID: 8363600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures.
    Taylor FB; Ward PA
    J Exp Med; 1967 Jul; 126(1):149-58. PubMed ID: 4226164
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Estrogen regulation of a tissue factor-like procoagulant in the immature rat uterus.
    Jazin EE; Dickerman HW; Henrikson KP
    Endocrinology; 1990 Jan; 126(1):176-85. PubMed ID: 2293981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The isolation and characterization of a ternary human plasmin B-chain-streptokinase-plasminogen complex.
    Summaria L; Boreisha I; Barlow GH; Robbins KC
    Thromb Haemost; 1987 Aug; 58(2):772-7. PubMed ID: 2960030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preclinical pharmacological evaluation of anisoylated plasminogen streptokinase activator complex.
    Ferres H
    Drugs; 1987; 33 Suppl 3():33-50. PubMed ID: 3315613
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ATP-regulated activity of the plasmin-streptokinase complex: a novel mechanism involving phosphorylation of streptokinase.
    Serrano RL; Rodriguez P; Pizzo SV; Gonzalez-Gronow M
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):171-7. PubMed ID: 8546680
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Catalytic properties of plasmin and the equimolar plasmin-streptokinase complex in their reactions with various substrates and inhibitors].
    Aĭsina RB; Zhitkova IuV; Fedorenko IaE; Kazanskaia NF
    Ukr Biokhim Zh (1978); 1991; 63(1):13-20. PubMed ID: 1827550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.